Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

Evaluation of a novel information resource for patients with bronchiectasis: study protocol for a randomised controlled trial

Authors: Katy L. M. Hester, Julia Newton, Tim Rapley, Anthony De Soyza

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

There is currently little patient information on bronchiectasis, a chronic lung disease with rising prevalence. Previous work shows that patients and their families want more information, which could potentially improve their understanding and self-management. Using interviews and focus groups, we have co-developed a novel patient and carer information resource, aiming to meet their identified needs.
The aims and objectives are:
1. To assess the potential impact of the information resource
2. To evaluate and refine the intervention
3. To establish the feasibility of carrying out a multi-centre randomised controlled trial to determine its effect on understanding, self-management and health outcomes

Methods/design

This is a feasibility study, with a single-centre, randomised controlled trial design, comparing use of a novel patient information resource to usual care in bronchiectasis. Additionally, patients and carers will be invited to focus groups to discuss their views on both the intervention itself and the trial process.
The study duration for each participant will be 3 months from the study entry date. A total of 70 patients will be recruited to the study, and a minimum of 30 will be randomised to each arm. Ten participants (and their carers if applicable) will be invited to attend focus groups on completion of the study visits. Participants will be adults with bronchiectasis diagnosed as per national bronchiectasis guidelines.
Once consented, participants will be randomised to the intervention or control arm using random permuted blocks to ensure treatment group numbers are evenly balanced. Randomisation will be web-based. Those randomised to the intervention will receive the information resource (website and booklet) and instructions on its use. Outcome measures (resource satisfaction, resource use and alternative information seeking, quality of life questionnaires, unscheduled healthcare visits, exacerbation frequency, bronchiectasis knowledge questionnaire and lung function tests) will be recorded at baseline, 2 weeks and 3 months.

Discussion

All outcome measures will be used in assessing feasibility and acceptability of a future definitive trial. Feasibility outcomes include recruitment, retention and study scale form completion rates. Focus groups will strengthen qualitative data for resource refinement and to identify participant views on the trial process, which will also inform feasibility assessments. Questionnaires will also be used to evaluate and refine the resource.

Trial registration

Appendix
Available only for authorised users
Literature
1.
Pasteur MC et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1277–84.CrossRefPubMed
2.
Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101(6):1163–70.CrossRefPubMed
3.
Wilson CB et al. Validation of the St. George’s Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):536–41.CrossRefPubMed
4.
O’Leary CJ et al. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002;96(9):686–92.CrossRefPubMed
5.
Hester KLM et al. Fatigue in bronchiectasis. Q J Med. 2012;105(3):235–40.CrossRef
6.
Macfarlane JG et al. Fatigue in bronchiectasis: its relationship to pseudomonas colonisation, dyspnoea and airflow obstruction. Thorax. 2010;65:A60.CrossRef
7.
Quint JK et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186–93.CrossRefPubMed
8.
Patel IS et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400–7.CrossRefPubMed
9.
Shahab L et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7.CrossRefPubMedPubMedCentral
10.
Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104(7):981–5.CrossRefPubMed
11.
Loebinger MR et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34(4):843–9.CrossRefPubMed
12.
Kelly MG, Murphy S, Elborn JS. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur J Intern Med. 2003;14(8):488–92.CrossRefPubMed
13.
14.
Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65 Suppl 1:i1–58.CrossRefPubMed
15.
Hester KLM, McAlinden P, De Soyza A. Education and information for patients with bronchiectasis: what do patients want? Eur Respir J. 2011;38(supplement 35):P3622.
16.
Lavery K et al. Self-management in bronchiectasis: the patients’ perspective. Eur Respir J. 2007;29(3):541–7.CrossRefPubMed
17.
Hester KLM, De Soyza A, Rapley T. Information and education needs of patients with bronchiectasis: a qualitative investigation. Thorax. 2012;67(supplement 2):A141.
18.
Hester KLM. Information and education provision for patients with bronchiectasis: a qualitative study. Newcastle upon Tyne: Newcastle University; 2012.
19.
Lancaster G, Dodd S, Williamson P. Design and analysis of pilot studies: recommendations for good practice. J Evaluation Clinical Practice. 2004;10(2):307–12.CrossRef
20.
McDonnell MJ et al. Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respiratory Medicine. 2015;109(6):716–26.CrossRefPubMed
21.
Bibby S, Milne R, Beasley R. Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand. New Zealand Med J. 2015;128(1421):30–8.PubMed
22.
Becker MH, Becker MH. Theoretical models of adherence and strategies for improving adherence. In: Shumaker SA, editor. The handbook of health behaviour change. New York: Springer Publishing Company; 1990. p. 5–43.
23.
Gibson PG et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev. 2002;2:CD001005.
24.
Partridge MR, Hill SR. Enhancing care for people with asthma: the role of communication, education, training and self-management. Eur Respir J. 2000;16(2):333–48.CrossRefPubMed
25.
Takakura S, Hasegawa T, Ishihara K. Assessment of patients’ understanding of their asthmatic condition established in an outpatient clinic. Eur Respir J. 1998;12(supplement 29):24S.
26.
Quittner AL, et al. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2014;0:1–9.
27.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia. 1983;67(6):361–70.CrossRef
28.
Fisk JD et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Dis. 1994;18(Supplement 1):S79–83.CrossRef
29.
Metadata
Title
Evaluation of a novel information resource for patients with bronchiectasis: study protocol for a randomised controlled trial
Authors
Katy L. M. Hester
Julia Newton
Tim Rapley
Anthony De Soyza
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1330-4

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue

Study protocol

Aiming to Improve Readmissions Through InteGrated Hospital Transitions (AIRTIGHT): study protocol for a randomized controlled trial

Research

Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency

Study protocol

Yoga versus education for Veterans with chronic low back pain: study protocol for a randomized controlled trial

Commentary

Improving the operational efficiency of Phase 2 and 3 trials

Erratum

Erratum to: ‘Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer’s maleate versus a glucose 5 %/potassium-based balanced solution: study protocol for a randomized controlled trial’

Research

Optimising the validity and completion of adherence diaries: a multiple case study and randomised crossover trial